Whistleblowers: Drug company offered 'bribes' to doctors to boost sales
cnn.com
cnn.com
Is the rapid increase of population part of the cause? Overpopulation often means the value of each individual will be decreased since anyone is now easily replaceable and becomes irrelevant. There are no signs this trend is going to stop anytime soon. I fear there has to be a massive catastrophic event to happen in order to trigger any societal changes at this level.
I think the diminishing value of humans/individuals is a result of overpopulation and industrialization. I don't remember who said it, but cities are now industrial farms for humans and a human being is a commodity/resource. In an industrial society, a human being is fundamentally no different than a cow or a pig on massive industrial farms. Our value is our commoditize productive value.
http://www.victorianweb.org/science/health/health1.html
Greed has always been a problem, a constant force we have to counteract.
Every single doctor here gets approached by multiple drug companies, being offered expensive vacations and similar perks (if not outright money) for prescribing the company's medications.
One particular doctor who is an absolutely disgusting and vile human being describes antibiotics for every ailment. He essentially ruined thousands of children's health for said perks. It got so bad the word spread in the town and apart from the least informed families no one took their children to this doctor if they could avoid it.
But this is just one doctor. The other 2 who practiced here also accepted rewards, but were a bit more sensible with it, but not by much. According to my aunt this is an incredibly widespread problem, and one that has been going on for decades.
I can't imagine anything more atrocious than sacrificing children's health for material gain. A person who is support to protect life and does this... I'm not religious and I seldom wish ill fate to people, but I do hope there is a hell for these kind of people.
2) the real problem is the legislation congress pushed through barring Medicare from negotiating drug prices. “Many of those sales are driven by Medicare reimbursements. A CNN investigation last year found that Medicare spending on Acthar had risen dramatically -- more than tenfold over six years -- to some $2 billion.” the article went ahead and glossed right over it, but if Medicare is your prime payer and can actually push back on price jumps, -this doesn’t happen-.
She is paid to take doctors on dinner dates, woo them and give them 'free samples', and ensure that they promote her product over all the others. She's admitted to me that she regularly has sex with her clients - and that she's a part of a larger team that covers the entire German market.
Its such a normal, accepted practice, that my surprise at her frank attitude about it was met with a "well, duh, how do you think we stay relevant in such a competitive market?" response ..
A few years ago a good friend of mine worked as an office manager for multiple gynaecologist offices in a major American city. Lots of small operations so she had multiple clients. She would always joke about the young women coming to push drugs on the doctors, almost all of whom were also women.
It's weird. It would seem to be as much a cultural aspect of sales workers as it is about actually using sex to sell drugs. I don't doubt that male doctors receive sex in exchange for pushing certain drugs, but I think there is a bit more to it as well. There seems to be an expectation that sales people need to be attractive, and if they're not the company doesn't take its business seriously.
I've never heard (in the US) of a practice of salespeople having sex with customers. I'd expect to hear a lot of lawsuits, were that a practice in the US.
It'd be sad if people who are just doing normal sales work (e.g., talking with the customer, understanding and communicating how product could work for them, negotiating deals) were insulted or had their reputations harmed by a suggestion that they were doing something else.
there is nothing unfair about people assuming or suspecting things, we do not regulate each other's thought processes.
MCI did the same shit back in their day. A sales visit from MCI almost always consisted of 1 each: redhead, blond, brunette all of whom looked like models.
I feel like there are ~3 groups of high priced drugs:
- straight up profiteering: this is the questcor playbook, that also inspired martin shkreli. companies find cheap old drugs that treat severe rare disease where they can get away with jacking up the price. The companies do no original r&d or new science. This is a rare practice these days and is highly stigmatized in the industry, as this type of practice kicked off a lot of the political debate around drug pricing
- increasing price of "legacy" drugs: big pharma is increasingly bad at r&d. The industry is also in a period where a lot of huge drugs are going off patent. So pharma companies increasingly rely on price increases of mature drugs, rather than development of new drugs, to sustain revenue growth. This is a much bigger phenomenon in dollar terms than the aforementioned profiteering. This is possible mostly for large molecule drugs because the "generic" pathway isn't as mature as small molecules, so the large molecule drugs can have exclusivity after patent expiry. Huge multi billion dollar drugs like humira and enbrel have done this a lot. Private payers are beginning to push back on this pretty effectively, and hopefully as the biosimilars industry matures this will improve.
- innovative, clinically valuable medicines. Some medicines are expensive because they are worth it in health economic terms. The cost per QALY gain is within the "acceptable" range. Most of the industry really does try to develop drugs like these (with varying degrees of conviction), but it's really hard. Companies ideally only want to develop drugs that are first in class or best in class. When that fails (which it usually does) they resort to aforementioned strategies. Unfortunately in many cases these innovative drugs are priced too high. They are often developed by startups and then bought by big pharma once the tech is derisked. Pharma is under huge pressure to grow revenue so they often price these meds too high. Which is a shame bc a lot are amazingly good medicines
Price isn't the only issue though, access is another, although they go hand in hand. Price can be "fair" but access still limited by payers. Copays for drugs are generally higher than for medical procedures, so consumers feel like drug prices are higher than medical procedures, when in reality they are all super high
Oh wow, such news.
In other shocking developments: water falls from the sky when it rains, and cigarettes are addictive.